Tirzepatide, sold under the brand names Mounjaro (for type 2 diabetes) and Zepbound (for obesity), is one of the most clinically significant medications to enter the weight management space in decades. As a dual GIP and GLP-1 receptor agonist, it targets two hormone pathways simultaneously, producing weight loss outcomes that have reached up to 22 percent of total body weight in clinical trials. For many patients, knowing how to use tirzepatide at home safely is the first pra